China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 30.97
(1.44%)
CNY 30.97
(1.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 74.19 Million CNY | 109.86% |
| 2022 | 35.35 Million CNY | -0.64% |
| 2021 | 35.58 Million CNY | -89.23% |
| 2020 | 330.39 Million CNY | -47.0% |
| 2019 | 623.38 Million CNY | 2.78% |
| 2018 | 606.5 Million CNY | 15.05% |
| 2017 | 527.14 Million CNY | 2280.42% |
| 2016 | 22.14 Million CNY | -50.95% |
| 2015 | 45.14 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 40 Million CNY | -39.85% |
| 2010 | 66.5 Million CNY | -31.09% |
| 2009 | 96.5 Million CNY | 127.06% |
| 2008 | 42.5 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 147.48 Million CNY | -97.33% |
| 2024 Q2 | 94.59 Million CNY | 287.36% |
| 2024 Q1 | 24.42 Million CNY | -67.09% |
| 2023 Q4 | 74.19 Million CNY | 202.34% |
| 2023 FY | 74.19 Million CNY | 109.86% |
| 2023 Q1 | 12.57 Million CNY | -64.43% |
| 2023 Q2 | 33.7 Million CNY | 168.01% |
| 2023 Q3 | 24.54 Million CNY | -27.19% |
| 2022 FY | 35.35 Million CNY | -0.64% |
| 2022 Q1 | 35.05 Million CNY | -1.48% |
| 2022 Q2 | 35.54 Million CNY | 1.4% |
| 2022 Q3 | 36.24 Million CNY | 1.97% |
| 2022 Q4 | 35.35 Million CNY | -2.46% |
| 2021 Q3 | 329.8 Million CNY | -0.14% |
| 2021 Q2 | 330.28 Million CNY | 157.95% |
| 2021 FY | 35.58 Million CNY | -89.23% |
| 2021 Q1 | 128.04 Million CNY | -61.25% |
| 2021 Q4 | 35.58 Million CNY | -89.21% |
| 2020 Q2 | 666.33 Million CNY | -15.39% |
| 2020 Q1 | 787.5 Million CNY | 26.33% |
| 2020 FY | 330.39 Million CNY | -47.0% |
| 2020 Q3 | 556.02 Million CNY | -16.56% |
| 2020 Q4 | 330.39 Million CNY | -40.58% |
| 2019 Q1 | 616.35 Million CNY | 1.62% |
| 2019 Q3 | 564.5 Million CNY | -17.93% |
| 2019 Q4 | 623.38 Million CNY | 10.43% |
| 2019 FY | 623.38 Million CNY | 2.78% |
| 2019 Q2 | 687.85 Million CNY | 11.6% |
| 2018 Q3 | 910 Million CNY | 3.16% |
| 2018 FY | 606.5 Million CNY | 15.05% |
| 2018 Q2 | 882.14 Million CNY | 40.66% |
| 2018 Q1 | 627.14 Million CNY | 18.97% |
| 2018 Q4 | 606.5 Million CNY | -33.35% |
| 2017 Q4 | 527.14 Million CNY | 80.44% |
| 2017 Q3 | 292.14 Million CNY | 0.0% |
| 2017 Q1 | 302.14 Million CNY | 1264.39% |
| 2017 Q2 | 292.14 Million CNY | -3.31% |
| 2017 FY | 527.14 Million CNY | 2280.42% |
| 2016 Q4 | 22.14 Million CNY | 0.0% |
| 2016 Q2 | 52.14 Million CNY | 135.47% |
| 2016 FY | 22.14 Million CNY | -50.95% |
| 2016 Q1 | 22.14 Million CNY | -50.95% |
| 2016 Q3 | 22.14 Million CNY | -57.53% |
| 2015 Q2 | 45 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 45.14 Million CNY | 0.0% |
| 2015 FY | 45.14 Million CNY | 0.0% |
| 2015 Q3 | 45.14 Million CNY | 0.32% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q1 | 40 Million CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2011 FY | 40 Million CNY | -39.85% |
| 2011 Q4 | 40 Million CNY | 0.0% |
| 2010 FY | 66.5 Million CNY | -31.09% |
| 2009 FY | 96.5 Million CNY | 127.06% |
| 2008 FY | 42.5 Million CNY | 0.0% |